Package 72974-120-95

Brand: orgovyx

Generic: relugolix
NDC Package Sample

Package Facts

Identity

Package NDC 72974-120-95
Digits Only 7297412095
Product NDC 72974-120
Product ID 72974-120_0d9200dd-878e-4e93-98af-e1149e84c21f
Description

16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95)

Marketing

Marketing Status
Marketed Since 2023-01-27
Brand orgovyx
Generic relugolix
Sample Package Yes

Linked Drug Pages (1)

Orgovyx ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0d9200dd-878e-4e93-98af-e1149e84c21f", "openfda": {"nui": ["N0000175839", "N0000175084", "N0000008638", "N0000190118", "N0000187064", "N0000190113", "N0000185503"], "unii": ["P76B05O5V6"], "rxcui": ["2472783", "2472789"], "spl_set_id": ["077a92f6-9f1b-479a-87c7-c92b5db6aa9c"], "pharm_class_pe": ["Decreased GnRH Secretion [PE]"], "pharm_class_epc": ["Gonadotropin Releasing Hormone Receptor Antagonist [EPC]"], "pharm_class_moa": ["Gonadotropin Releasing Hormone Receptor Antagonists [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Sumitomo Pharma America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01)", "package_ndc": "72974-120-01", "marketing_start_date": "20201218"}, {"sample": true, "description": "16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95)", "package_ndc": "72974-120-95", "marketing_start_date": "20230127"}, {"sample": true, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97)", "package_ndc": "72974-120-97", "marketing_start_date": "20211021"}], "brand_name": "Orgovyx", "product_id": "72974-120_0d9200dd-878e-4e93-98af-e1149e84c21f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased GnRH Secretion [PE]", "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]", "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "72974-120", "generic_name": "relugolix", "labeler_name": "Sumitomo Pharma America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Orgovyx", "active_ingredients": [{"name": "RELUGOLIX", "strength": "120 mg/1"}], "application_number": "NDA214621", "marketing_category": "NDA", "marketing_start_date": "20201218", "listing_expiration_date": "20261231"}